Table 5 of Paylakhi, Mol Vis 2012; 18:241-254.
Group no. | miRNA with enriched targets | No. target genes (No. genes in group) | Target genes | p value |
---|---|---|---|---|
3 | HSA-MIR-29A.5 | 8 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A1, COL5A2, COL7A1, COL11A1 | 2.85E-09 |
3 | HSA-MIR-29C.5 | 8 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A1, COL5A2, COL7A1, COL11A1 | 5.12E-09 |
3 | HSA-MIR-29B.5 | 7 (10) | COL4A1, COL4A2, COL4A5, COL5A1, COL5A2, COL7A1, COL11A1 | 3.91E-07 |
3 | HSA-MIR-29A.4 | 8 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A1, COL5A2, COL7A1, COL11A1 | 8.04E-07 |
3 | HSA-MIR-29B.4 | 8 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A1, COL5A2, COL7A1, COL11A1 | 9.36E-07 |
3 | HSA-MIR-29C.4 | 8 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A1, COL5A2, COL7A1, COL11A1 | 1.05E-06 |
3 | HSA-LET-7A.4 | 6 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A1, COL5A2 | 0.0014 |
3 | HSA-LET-7C.4 | 6 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A1, COL5A2 | 0.0015 |
3 | HSA-LET-7B.4 | 6 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A1, COL5A2 | 0.0017 |
3 | HSA-LET-7G.4 | 5 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A2 | 0.01 |
3 | HSA-LET-7F.4 | 5 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A2 | 0.01 |
3 | HSA-LET-7E.4 | 5 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A2 | 0.01 |
3 | HSA-LET-7I.4 | 5 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A2 | 0.01 |
3 | HSA-MIR-98.4 | 5 (10) | COL1A1, COL4A1, COL4A2, COL4A5, COL5A2 | 0.01 |
11 | HSA-MIR-657.4 | 5 (13) | FKTN, UST, GALNT10, XYLT1, GLT8D2 | 0.01 |
13 | HSA-MIR-517B.4 | 5 (49) | SLC2A3, SCARA3, ORAI2, MBOAT2, C9ORF91 | 0.01 |
13 | HSA-MIR-188–3P.4 | 5 (49) | SLC7A11, FAM119B, D4S234E, FAM171A1, FAM155A | 0.03 |
14 | HSA-MIR-26A.5 | 6 (33) | CDK6, DAPK1, PDGFRA, MAP3K2, STK39, TRIB2 | 0.01 |
14 | HSA-MIR-34A.5 | 5 (33) | AXL, CDK6, EPHA4, MET, PDGFRA | 0.01 |
14 | HSA-MIR-34C-5P.4 | 7 (33) | AXL, CDK6, EPHA4, MET, PDGFRA, IKBKE, STK39 | 0.01 |
14 | HSA-MIR-34A.4 | 6 (33) | AXL, CDK6, EPHA4, MET, PDGFRA, PRKD1 | 0.01 |
14 | HSA-MIR-26B.4 | 7 (33) | CDK6, DAPK1, PDGFRA, WEE1, MAP3K2, STK39, TRIB2 | 0.02 |
14 | HSA-MIR-381.4 | 7 (33) | EPHA4, GRK5, MET, RPS6KA3, TEK, WEE1, ZAK | 0.02 |
14 | HSA-MIR-449B.4 | 5 (33) | AXL, CDK6, EPHA4, PDGFRA, IKBKE | 0.02 |
14 | HSA-MIR-26A.4 | 7 (33) | CDK6, DAPK1, PDGFRA, WEE1, MAP3K2, STK39, TRIB2 | 0.02 |
14 | HSA-MIR-519C-5P.4 | 8 (33) | AXL, CDK6, EPHA4, MYLK, PTK7, RPS6KA3, MAP3K2, ZAK | 0.02 |
14 | HSA-MIR-26B.5 | 5 (33) | CDK6, DAPK1, MAP3K2, STK39, TRIB2 | 0.02 |
14 | HSA-MIR-485–3P.4 | 5 (33) | CDK6, DAPK1, MET, MELK, TRIB2 | 0.03 |
14 | HSA-MIR-323–3P.4 | 6 (33) | DAPK1, MET, RPS6KA3, SGK1, MELK, MAP3K2 | 0.03 |
14 | HSA-MIR-32.4 | 6 (33) | AXL, CDK6, SGK1, AATK, STK39, ZAK | 0.04 |
18 | HSA-MIR-124.4 | 7 (19) | AHR, E2F3, ELF4, ETS1, MITF, PLAGL2, SOX9 | 0.01 |
18 | HSA-MIR-145.4 | 5 (19) | KLF5, ETS1, MAF, PLAGL2 SOX9 | 0.02 |
18 | HSA-MIR-32.4 | 5 (19) | E2F3, GATA2, MITF, SOX4, HAND1 | 0.02 |